BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 108 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,164,000 | +2.6% | 20,443 | -3.6% | 0.03% | 0.0% |
Q3 2019 | $1,135,000 | -19.0% | 21,213 | -9.7% | 0.03% | -18.8% |
Q2 2019 | $1,402,000 | +125.8% | 23,488 | +135.6% | 0.03% | +128.6% |
Q1 2019 | $621,000 | +2.8% | 9,968 | 0.0% | 0.01% | -6.7% |
Q4 2018 | $604,000 | -9.0% | 9,968 | -34.9% | 0.02% | 0.0% |
Q4 2017 | $664,000 | -6.9% | 15,316 | 0.0% | 0.02% | -6.2% |
Q3 2017 | $713,000 | -5.9% | 15,316 | 0.0% | 0.02% | -5.9% |
Q2 2017 | $758,000 | +58.2% | 15,316 | +75.1% | 0.02% | +54.5% |
Q1 2017 | $479,000 | -1.6% | 8,749 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $487,000 | +21.8% | 8,749 | 0.0% | 0.01% | +22.2% |
Q3 2016 | $400,000 | +14.6% | 8,749 | 0.0% | 0.01% | +12.5% |
Q2 2016 | $349,000 | +58.6% | 8,749 | +71.1% | 0.01% | +60.0% |
Q4 2015 | $220,000 | -1.3% | 5,113 | 0.0% | 0.01% | -16.7% |
Q3 2015 | $223,000 | – | 5,113 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 211,370 | $9,833,000 | 5.80% |
JW Asset Management, LLC | 73,649 | $3,426,000 | 2.51% |
NORTHPOINTE CAPITAL LLC | 135,657 | $6,311,000 | 0.67% |
Elk Creek Partners, LLC | 170,102 | $7,913,000 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 156,167 | $7,265,000 | 0.32% |
Ativo Capital Management LLC | 22,592 | $1,051,000 | 0.28% |
Matarin Capital Management, LLC | 59,077 | $2,748,262,000 | 0.23% |
ISTHMUS PARTNERS, LLC | 16,753 | $779,000 | 0.22% |
CADENCE CAPITAL MANAGEMENT LLC | 29,586 | $1,376,000 | 0.09% |
ALGERT GLOBAL LLC | 7,834 | $364,000 | 0.08% |